AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3316518
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine added to metoclopramide and dexamethasone
Trial: 31763732
Drug: Novel combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel combination powder (CP) - HEMOBLAST Bellows; Biom'up, France
Trial: 30224318
Drug: Nintedanib 100
RxNorm normalized name: nintedanib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 100 mg twice daily
Trial: 26561294
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy at high-enrolling sites
Trial: 26561294
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy at low-enrolling sites
Trial: 26561294
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment groups at high-enrolling sites
Trial: 26561294
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment groups at low-enrolling sites
Trial: 21130380
Drug: Ecallantide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecallantide (30 mg subcutaneous)
Trial: 2944997
Drug: Etodolac 400
RxNorm normalized name: etodolac 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac 400 mg
Trial: 30912285
Drug: Ketone salts
RxNorm normalized name: Ketonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketone salts (0.3 g β‐OHB per kg)
Trial: 30912285
Drug: Ketone monoester
RxNorm normalized name: Ketonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketone monoester (0.482 g β‐OHB per kg)
Trial: 29049251
Drug: Esmolol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 0.5 mg/kg
Trial: 20329604
Drug: Bailing Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bailing Capsule (BLC)
Trial: 17877513
Drug: EBAL (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBAL (esomeprazole 40 mg b.d., bismuth subcitrate 240 mg b.d., amoxicillin 1 g b.d. and levofloxacin 500 mg b.d.)
Trial: 17877513
Drug: EBMT (esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBMT (esomeprazole 40 mg b.d., bismuth subcitrate 240 mg b.d., metronidazole 400 mg t.d.s. and tetracycline 500 mg q.d.s.)
Trial: 2653325
Drug: Bezafibrate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (400 mg daily for 2 months)
Trial: 31359804
Drug: S-amlodipine 5
RxNorm normalized name: S-amlodipine
DrugBank: Levamlodipine (DB09237)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-amlodipine 5 mg for 10 days followed by S-amlodipine 5 mg plus bisoprolol 5 mg for 7 days
Trial: 21667769
Drug: Explicit handwriting
RxNorm normalized name: Empliciti
DrugBank: Elotuzumab (DB06317)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Explicit handwriting program (two weekly sessions of 45 min. over six weeks)
Trial: 21667769
Drug: Regular handwriting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular handwriting program (one weekly session)
Trial: 16641143
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (ergocalciferol 2.5 mg every 3 months, equivalent to a daily dose of 1,100 IU)
Trial: 2142172
Drug: Aqueous cream
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous cream
Trial: 22065400
Drug: bosutinib 500
RxNorm normalized name: bosutinib 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bosutinib 500 mg with food (therapeutic)
Trial: 16020405
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg/day (increased to 10 mg as tolerated)
Trial: 9857885
Drug: Lamifiban (GP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamifiban (GP IIb/IIIa inhibitor)
Trial: 23756346
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules (750mg docosahexaenoic plus eicosapentaenoic acids, and 60mg gamma linolenic acid/school day) during Phase 1
Trial: 23756346
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules (after crossover in Phase 2)
Trial: 18856250
Drug: Timed oral
RxNorm normalized name: C-Time Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed oral care (toothbrushing every 8 hours)
Trial: 18856250
Drug: Usual oral
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual oral care (control group)
Trial: 16243588
Drug: Elemene injections
RxNorm normalized name: (-)-beta-Elemene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemene injections
Trial: 3900905
Drug: Rifampin, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin, 10 mg/kg, twice a day for four days
Trial: 3900905
Drug: Placebo, once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, once daily for four days
Trial: 3900905
Drug: All drug
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drug regimens (including placebo)
Trial: 3900905
Drug: Anticapsular antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticapsular antibody concentration measurement
Trial: 19921230
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (8 IU)
Trial: 29750971
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (1 IU)
Trial: 24839144
Drug: Lactoferrin (LF)
DrugBank: Lactoferrin (DB16555)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactoferrin (LF) 200 mg/d
Trial: 20590588
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone (0.2 mg x kg(‐1)) alone
Trial: 15795705
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg losartan
Trial: 11850708
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus ursodiol
Trial: 21459941
Drug: Milnacipran 100
RxNorm normalized name: milnacipran 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran 100 mg/day (PBO:MLN100)
Trial: 15632102
Drug: Metformin 2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 2,000 mg/day
Trial: 9647682
Drug: Dual task
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual task during encoding with concurrent articulatory suppression
Trial: 2661738
Drug: Whole-brain irradiation
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-brain irradiation (6020 rads) concurrent with chemotherapy
Trial: 26821769
Drug: 0.5 kg/mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 kg/mg ketamine and 0.2 kg/mg ketamine
Trial: 22537767
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol (2 mg/day)
Trial: 21934534
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol combined with medroxyprogesterone acetate (MPA; 5 mg/day)
Trial: 8487512
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (engaged strictly in skill activities daily)
Trial: 30571543
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of pyridostigmine 60 mg and atomoxetine 18 mg
Trial: 17515448
Drug: Atomoxetine 18
RxNorm normalized name: atomoxetine 18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 18 mg
Trial: 31563866
Drug: Monthly ranibizumab
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Monthly ranibizumab
Trial: 21797667
Drug: Brimonidine 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine 0.1% eye drops twice daily
Trial: 21797667
Drug: Placebo eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo eye drops administered to the other eye twice daily
Trial: 17651149
Drug: High-dose inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose inhaled corticosteroids (ICS)
Trial: 15100679
Drug: Medium-dose or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose or high-dose inhaled corticosteroids (ICS) or oral corticosteroids
Trial: 2501775
Drug: Topical mupirocin
RxNorm normalized name: mupirocin Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical mupirocin
Trial: 31595704
Drug: Tablet formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet formulation (R)
Trial: 31595704
Drug: Disintegrating tablet
RxNorm normalized name: Clozapine Orally Disintegrating Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disintegrating tablet formulation (T)
Trial: 19063816
Drug: Olopatadine 0.2%
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olopatadine 0.2% ophthalmic solution
Trial: 10657867
Drug: No G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No G-CSF (Control)
Trial: 9305321
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg citicoline
Trial: 9305321
Drug: Citicoline (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline (all doses)
Trial: 31701163
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (40 IU)
Trial: 28914726
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy for insomnia specific to bipolar disorder (CBTI‐BP)
Trial: 22098090
Drug: Probiotic yoghurt
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic yoghurt (200 g/d for 9 weeks)
Trial: 22098090
Drug: Conventional yoghurt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional yoghurt (200 g/d for 9 weeks)
Trial: 17287908
Drug: Vitamin K2
RxNorm normalized name: Vitamin K2
DrugBank: Menaquinone 6 (DB14936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K2 (MK-4, menatetrenone) 45 mg/day
Trial: 7908358
Drug: Very-low-dose warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-low-dose warfarin
Trial: 2650797
Drug: TP-5 50
RxNorm normalized name: OTX-TP
DrugBank: Travoprost (DB00287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: TP-5 50 mg three times a week for 3 weeks
Trial: 25311447
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D(3) 5000 IU daily
Trial: 6383832
Drug: Verapamil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (0.1 mg kg-1 i.v. on admission followed by 120 mg perorally t.i.d. for 6 months)
Trial: 23586456
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment incorporating aspects of imaginal desensitization and motivational interviewing
Trial: 11574441
Drug: Fidarestat (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fidarestat (1 mg daily for 52 weeks)
Trial: 8800732
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy plus methotrexate (n = 17)
Trial: 8800732
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (n = 19)
Trial: 27760494
Drug: Angle-class, midline-displacement,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angle-class, midline-displacement, crossbite, or orthodontic therapy
Trial: 23274597
Drug: 2.8 mg·kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.8 mg·kg BM of PSE
Trial: 17369520
Drug: Intramuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular electrical stimulation (n = 32)
Trial: 25170553
Drug: Quadrivalent human
RxNorm normalized name: PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent human papillomavirus vaccine (HPV4) before concomitantly administered vaccines
Trial: 25170553
Drug: Quadrivalent human
RxNorm normalized name: PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent human papillomavirus vaccine (HPV4) after concomitantly administered vaccines
Trial: 26721134
Drug: Acupuncture-moxibustion treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-moxibustion treatment
Trial: 15373869
Drug: Topical spray
RxNorm normalized name: Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical spray
Trial: 7653745
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 100 micrograms four times daily
Trial: 2892143
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg daily) + Hydrochlorothiazide (50 mg daily)
Trial: 2832575
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg daily) + Atenolol (50 mg daily)
Trial: 2892143
Drug: Beta-blockers and
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers and Diuretics
Trial: 23849325
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg nifedipine and 32 mg candesartan FDC
Trial: 23849325
Drug: Loose combination
RxNorm normalized name: loose wheat smut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loose combination of 60 mg nifedipine GITS and 32 mg candesartan
Trial: 23849325
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg nifedipine GITS alone
Trial: 23849325
Drug: 32 mg
RxNorm normalized name: caffeine 32 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 mg candesartan alone
Trial: 12925476
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine 0.2 mg
Trial: 12925476
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine 0.3 mg
Trial: 12925476
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine 0.4 mg
Trial: 9523865
Drug: F13 (13
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F13 (13 g/l protein)
Trial: 9523865
Drug: F15 (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F15 (15 g/l protein)
Trial: 8816618
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRH‐a)
Trial: 21105835
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive pills (OCPs)
Trial: 7714086
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of OCPs and GnRH‐a
Trial: 2692963
Drug: 50 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 micrograms ethinyl estradiol (EE) and 1.0 mg norethindrone (NE)
Trial: 2692963
Drug: 35 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 micrograms ethinyl estradiol (EE) and 1.0 mg norethindrone (NE)
Trial: 2692963
Drug: 35 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 micrograms ethinyl estradiol (EE) and 0.5 mg norethindrone (NE)
Trial: 29635379
Drug: Apremilast 20
RxNorm normalized name: apremilast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apremilast 20 mg twice a day
Trial: 29635379
Drug: Apremilast 30
RxNorm normalized name: apremilast 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apremilast 30 mg twice a day
Trial: 25779750
Drug: MRI substudy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI substudy (both apremilast doses)
Trial: 22120252
Drug: Intravenous nimodipine
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nimodipine
Trial: 18694222
Drug: Novel combinations
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel combinations of existing open source solutions
Trial: 9625339
Drug: Theophylline (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (4 mg/kg then 2 mg/kg twice daily)
Trial: 7908778
Drug: Azelastine 2
RxNorm normalized name: azelastine 2.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 2 sprays/nostril q24h
Trial: 7908778
Drug: Azelastine 2
RxNorm normalized name: azelastine 2.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine 2 sprays/nostril q12h
Trial: 7908778
Drug: Oral chlorpheniramine
RxNorm normalized name: chlorpheniramine Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral chlorpheniramine maleate 12 mg q12h
Trial: 3261158
Drug: Fiberoptic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiberoptic injection sclerotherapy (FIS)
Trial: 26456372
Drug: Roflumilast 100
RxNorm normalized name: Roflumilast
DrugBank: Roflumilast (DB01656)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Roflumilast 100 μg, 250 μg, or 500 μg once daily
Trial: 26456372
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 400 μg or 500 μg twice daily
Trial: 14550680
Drug: Nefazodone (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone (maximum dose 600 mg/day)
Trial: 11108760
Drug: Traditional upper-extremity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional upper-extremity (UE) therapies
Trial: 1305840
Drug: Paracetamol (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (with or without codeine)
Trial: 6289058
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg twice a day)
Trial: 29846604
Drug: 1% transdermal
RxNorm normalized name: Androgel 1% Transdermal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% transdermal testosterone gel applied daily for 3 years
Trial: 29846604
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied daily for 3 years
Trial: 23150707
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation with fluorouracil (FU) plus mitomycin (MMC)
Trial: 23150707
Drug: Induction plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction plus concurrent fluorouracil (FU) plus cisplatin (CDDP)
Trial: 29124549
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy with surgical resection
Trial: 27811855
Drug: Home-based walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based walking exercise training and weekly exercise counseling
Trial: 12391059
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g/day for 4 days, then 2 g/day for 17 days)
Trial: 19730217
Drug: Epsilon aminocaproic
RxNorm normalized name: Epsilon Aminocaproic Acid
DrugBank: Aminocaproic acid (DB00513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epsilon aminocaproic acid (EACA) 100 mg/kg
Trial: 8646867
Drug: Betamethasone-17,21-dipropionate ointment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone-17,21-dipropionate ointment, 0.05%
Trial: 30412068
Drug: Pharmacologic agents
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic agents
Trial: 27344046
Drug: Budesonide/formoterol (BF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (BF) 320/9 μg delivered by Spiromax
Trial: 27344046
Drug: Budesonide/formoterol (BF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (BF) 320/9 μg delivered by Turbuhaler
Trial: 22313076
Drug: Granisetron 10
RxNorm normalized name: GRANISETRON 10MG/0.4ML INJ,SYRINGE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 10 µg/kg diluted in 10 ml saline 0.9% intravenously (group 1, n=40)
Trial: 22313076
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 ml 0.9% saline, group 2, n=40)
Trial: 20002510
Drug: Adapted U.S.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapted U.S. model of pharmaceutical care
Trial: 16257339
Drug: Gefitinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (250 mg/day) plus best supportive care